-
Eli Lilly will cap prices for many people with diabetes
Eli Lilly and Co said it will immediately cap out-of-pocket costs for insulin patients who are not covered by the recent Medicare Part D cap. This comes after the US Centers for Disease Control and Prevention said that over 37.3 million people have diabetes in the country, of which 25.8 million are adults. The average…
-
Eli Lilly limits the out-of-pocket cost of their drug to $35 a month
US drugmaker Eli Lilly will immediately cap monthly out-of-pocket costs for people who aren’t covered by Medicare at $35 (over 2,300) per month if insurers and the pharmacy system don’t implement its price cuts soon. The average retail price of insulin in the US has gone up in the last few years, reported GoodRx. Over…